How Not to Study a Disease
Autor Karl Herrupen Limba Engleză Paperback – 7 mar 2023
Preț: 111.93 lei
Preț vechi: 135.46 lei
-17%
Puncte Express: 168
Carte disponibilă
Livrare economică 20-27 iulie
Livrare prin curier în România Termenul estimat este afișat lângă disponibilitate.
Transport gratuit de la 400.00 lei Plată online sau ramburs, în funcție de opțiunile comenzii.
Retur gratuit în 14 zile Comandă securizată și suport în română.
Specificații
ISBN-13: 9780262546010
ISBN-10: 0262546019
Pagini: 272
Ilustrații: 28 b&w illustrations
Dimensiuni: 140 x 218 x 20 mm
Greutate: 0.36 kg
Editura: Mit Press
ISBN-10: 0262546019
Pagini: 272
Ilustrații: 28 b&w illustrations
Dimensiuni: 140 x 218 x 20 mm
Greutate: 0.36 kg
Editura: Mit Press
Cuprins
Prologue ix
I In the Beginning 1
1 A Layperson's History of Alzheimer's Disease 3
2 A Physician's History of Alzheimer's Disease 23
3 A Scientist's History of Alzheimer's Disease 33
4 Mystery Solved! How Four Discoveries Transformed an Entire Field 53
II What Happened to our Cure? 71
5 Building a Model of Alzheimer's Disease 73
III Double-Edged Swords 97
6 Federal Support of Basic Biomedical Research 99
7 The Pharmaceutical and Biotech Industry 115
8 Testing Our Models: Breaking Bad 131
9 What is Alzheimer's Disease? 149
IV Where Shall We Go From Here? 169
10 A Layperson's Guide to the Biology of Aging 171
11 Building a New Model of Alzheimer's Disease 187
12 Rebalancing our Research Portfolio 207
13 Rebalancing our Institutions 227
14 Final Thoughts 243
Acknowledgments 247
Notes 249
Index 255
I In the Beginning 1
1 A Layperson's History of Alzheimer's Disease 3
2 A Physician's History of Alzheimer's Disease 23
3 A Scientist's History of Alzheimer's Disease 33
4 Mystery Solved! How Four Discoveries Transformed an Entire Field 53
II What Happened to our Cure? 71
5 Building a Model of Alzheimer's Disease 73
III Double-Edged Swords 97
6 Federal Support of Basic Biomedical Research 99
7 The Pharmaceutical and Biotech Industry 115
8 Testing Our Models: Breaking Bad 131
9 What is Alzheimer's Disease? 149
IV Where Shall We Go From Here? 169
10 A Layperson's Guide to the Biology of Aging 171
11 Building a New Model of Alzheimer's Disease 187
12 Rebalancing our Research Portfolio 207
13 Rebalancing our Institutions 227
14 Final Thoughts 243
Acknowledgments 247
Notes 249
Index 255